Latest news with #Injective
Business Mayor
24-05-2025
- Business
- Business Mayor
Injective leads AI token surge with 12% rise – Is $17 possible for INJ?
INJ, on the daily time frame, completed a clean inverse heads and shoulders pattern. Injective's $2B annualized trading volume for iAssets could accelerate the onboarding of tokenized stocks & RWAs. The altcoins are back to performance with most AI tokens, including Injective [INJ] and Artificial Superintelligence Alliance [FET] among others, gaining ground after potentially finishing the correction. Price analysis and market sentiment Injective completed an inverse head and shoulders pattern on the daily timeframe, and a breakout verified at the $11.16 level. Once it settled above the neckline, INJ made a big move up, rising 12% in just a day. The volume followed with an 87% daily rise. The price crossed both the 50-day EMA at $10.81 and the 100-day SMA at $11.16 and continued rising, showing momentum was bullish, and the trend could keep going. As trading increased on the breakout, it proved the structure was strong after the crossover. Should Injective's price remain supported at the neckline and by both averages, it could continue moving upwards and test the $16.50 to $17.00 level in the short run. Source: TradingView However, a failure to hold above $15.00 may trigger a slide back to $12.80—or, in a deeper retracement, to the 100-day SMA near $11.16. If that level breaks, the bullish setup would likely invalidate, opening room for downside risk. At the same time, statistics showed over 95% of respondents thought JasmyCoin [JASMY] and Injective were poised for growth. Due to the strong investor conviction, INJ was probably doing well following ongoing media appearances, keeping the project in the limelight. Read More How FTX can impact ETH's future price movements There were also sentiments of 94.90%, 94.70% and 93.40% for Jupiter [JUP], Virtuals Protocol [VIRTUAL] and Cardano [ADA], respectively. With both INJ's high ratings and the momentum, there was a real chance the protocol's ecosystem could grow over the long term. Injective's annualized volume for iAssets The media presence also helped. Ongoing exposure—including Eric Chen's recent appearance on CNBC—keeps INJ in the spotlight, boosting investor confidence. On top of price action, Injective recently hit a $2 billion annualized trading volume for its tokenized assets (iAssets). These include tokenized stocks and real-world assets (RWAs), key growth areas that are drawing both institutional and retail interest. Source: X While publicity from the DAO can lift the project's credibility, INJ's price responsiveness would rely on continuous platform implementation and changes in the market. An increase in institutional interest could bring upside movement to INJ. However, future growth needed the network to attract users and for the overall market to improve.
CNBC
21-05-2025
- Business
- CNBC
Bitcoin falls after hitting new record high of $109,500: CNBC Crypto World
On today's episode of CNBC Crypto World, Bitcoin sets a new record price. Plus, the SEC files charges against the crypto firm Unicoin and its top executives for alleged fraud. And, Eric Chen, co-founder of Injective, reacts to bitcoin's new record and provides his outlook for the cryptocurrency.
Business Mayor
12-05-2025
- Business
- Business Mayor
Injective price jumps as bulls extend gains amid Bitcoin spike
Injective price is extending gains above the $10 mark. Bitcoin's rally above $105k and real-world assets tokenization catalysts could drive the INJ price higher. INJ technical outlook is largely bullish. Injective (INJ) is among the top-performing altcoins on Monday as bullish sentiment sweeps through the cryptocurrency market. The token is trading above $13.60, lifted by renewed investor confidence following Bitcoin's surge past $105,000. With macroeconomic optimism and progress on regulatory fronts driving broader market momentum, analysts suggest Bitcoin could challenge new all-time highs in the near term. This backdrop is fuelling capital rotation into altcoins, with projects like Injective benefiting from increased speculative interest. A layer-1 blockchain focused on decentralised finance and real-world asset tokenization, Injective has continued to attract attention as narratives around scalability and use-case-driven growth gain ground. Injective price extends gains above $10 Injective (INJ) price is up 7% in the past 24 hours, gaining as top alts such as Ethereum, BNB, and Solana break to key levels. The price of INJ has surged after recently breaking past the $10 mark. Currently, it changes hands for around $13.62. However, it hovered at highs of $14.29 on May 12, 2025, to hit its highest level since late February. Amid the price gains, Injective's market cap rose to $1.37 billion, although the 24-hour trading volume remained modest at $172 million. Having surged 46% in seven days and 67% in the last 30 days, the overall market interest might see bulls take control. Bitcoin rally and RWA tokenization drive INJ price While Bitcoin's rally is fueling further optimism across the market, catalysts for INJ price also include strong institutional demand across its RWA ecosystem. Tokenization is a key tailwind for Injective, with a recent Four Pillars report highlighting how this sector is shaping up INJ for traction. Recent bull cycles have had DeFi, play-to-earn games, memecoins, and AI tokens explode. Now, analysts say while these areas see growth, the RWA market's growth has blockchains like Injective in the spotlight. Injective's network, optimized for the tokenization of traditional assets like stocks, stablecoins, and commodities, stands as a likely beneficiary. Investors eyeing an on-chain opportunity are increasingly seeing it as the go-to platform. RWA adoption may further boost INJ's price momentum. Injective price technical outlook From a technical perspective, INJ's daily chart paints a bullish picture. INJ chart by TradingView The daily Relative Strength Index (RSI) currently hovers in overbought territory. However, it's not overly extended to suggest more room for bulls. If it sees a pullback, INJ will likely bounce off support around $11.05 and $10.22. This scenario may align with the Moving Average Convergence Divergence (MACD), which shows a bullish crossover. The histogram indicates an upward momentum. If this happens, bulls will target $16 and then $20.
